EP 1597587 A2 20051123 - DIAGNOSIS OF ALZHEIMER DISEASE BY THE DETERMINATION OF G-PROTEIN COUPLED RECEPTOR HM74A (HM74A)
Title (en)
DIAGNOSIS OF ALZHEIMER DISEASE BY THE DETERMINATION OF G-PROTEIN COUPLED RECEPTOR HM74A (HM74A)
Title (de)
DIAGNOSE VON ALZHEIMER DURCH DIE BESTIMMUNG VON G-PROTEIN GEKOPPELTEN REZEPTOR HM74A (HM74A)
Title (fr)
METHODE DIAGNOSTIQUE DE LA MALADIE D'ALZHEIMER PAR LA DETERMINATION DU RECEPTEUR HM74A COUPLE A LA PROTEINE G
Publication
Application
Priority
- EP 2004001056 W 20040205
- EP 03003534 A 20030217
- EP 04708345 A 20040205
Abstract (en)
[origin: WO2004071378A2] The invention provides a human HM74a which is associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of HM74a as well as pharmaceutical compositions comprising such compounds.
IPC 1-7
G01N 33/74; A61K 38/17; A61K 48/00; A61P 25/00; A61P 9/00; A61P 7/00; A61P 35/00; A61P 29/00; A61P 13/00; A61P 11/00; A61P 1/00
IPC 8 full level
A61K 38/17 (2006.01); A61K 48/00 (2006.01); A61P 1/00 (2006.01); A61P 7/00 (2006.01); A61P 9/00 (2006.01); A61P 11/00 (2006.01); A61P 13/00 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); G01N 33/566 (2006.01); G01N 33/74 (2006.01)
CPC (source: EP US)
A61K 38/177 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 13/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); G01N 33/566 (2013.01 - EP US); G01N 33/74 (2013.01 - EP US); G01N 2333/726 (2013.01 - EP US); G01N 2500/00 (2013.01 - EP US)
Citation (search report)
See references of WO 2004071378A2
Citation (examination)
SCHNEIDER M.: "A rational Approach to maximize success rate in target discovery.", ARCH. PHARM. PHARM. MED. CHEM., vol. 337, 2004, pages 625 - 633, XP002553686, DOI: doi:10.1002/ardp.200400913
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004071378 A2 20040826; WO 2004071378 A3 20050106; EP 1597587 A2 20051123; US 2006160132 A1 20060720; US 7465548 B2 20081216
DOCDB simple family (application)
EP 2004001056 W 20040205; EP 04708345 A 20040205; US 54461504 A 20040205